SG43071A1 - Urethanes and ureas that induce cytokine production - Google Patents

Urethanes and ureas that induce cytokine production

Info

Publication number
SG43071A1
SG43071A1 SG1996003270A SG1996003270A SG43071A1 SG 43071 A1 SG43071 A1 SG 43071A1 SG 1996003270 A SG1996003270 A SG 1996003270A SG 1996003270 A SG1996003270 A SG 1996003270A SG 43071 A1 SG43071 A1 SG 43071A1
Authority
SG
Singapore
Prior art keywords
urethanes
cytokine production
ureas
compounds
formula
Prior art date
Application number
SG1996003270A
Other languages
English (en)
Inventor
Semiramis Ayral-Kaloustian
Stevev R Schow
Mila T Du
Jame J Gibbons Jr
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of SG43071A1 publication Critical patent/SG43071A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SG1996003270A 1993-05-12 1994-04-20 Urethanes and ureas that induce cytokine production SG43071A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/063,174 US5312831A (en) 1993-05-12 1993-05-12 Urethanes and ureas that induce cytokine production

Publications (1)

Publication Number Publication Date
SG43071A1 true SG43071A1 (en) 1997-10-17

Family

ID=22047440

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996003270A SG43071A1 (en) 1993-05-12 1994-04-20 Urethanes and ureas that induce cytokine production

Country Status (26)

Country Link
US (6) US5312831A (cs)
EP (1) EP0652228B1 (cs)
JP (1) JP3583469B2 (cs)
KR (1) KR100296543B1 (cs)
CN (1) CN1094943C (cs)
AT (1) ATE144533T1 (cs)
AU (1) AU669064B2 (cs)
CA (1) CA2123261A1 (cs)
CZ (1) CZ290445B6 (cs)
DE (1) DE69400798T2 (cs)
DK (1) DK0652228T3 (cs)
ES (1) ES2094004T3 (cs)
FI (1) FI942186A7 (cs)
GR (1) GR3022253T3 (cs)
HU (1) HU219768B (cs)
IL (1) IL109602A (cs)
NO (1) NO311223B1 (cs)
NZ (1) NZ260507A (cs)
PH (1) PH30182A (cs)
PL (1) PL179984B1 (cs)
RU (1) RU2135515C1 (cs)
SG (1) SG43071A1 (cs)
SI (1) SI0652228T1 (cs)
SK (1) SK281120B6 (cs)
TW (1) TW380129B (cs)
ZA (1) ZA943266B (cs)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1007183A3 (fr) * 1993-06-18 1995-04-18 Solvay Ureines derivees d'alpha, omega-diaminoacides et procede pour leur preparation.
JPH11503110A (ja) 1995-02-17 1999-03-23 スミスクライン・ビーチャム・コーポレイション Ｉｌ−８受容体拮抗剤
US6005008A (en) * 1996-02-16 1999-12-21 Smithkline Beecham Corporation IL-8 receptor antagonists
US6211373B1 (en) 1996-03-20 2001-04-03 Smithkline Beecham Corporation Phenyl urea antagonists of the IL-8 receptor
US6262113B1 (en) 1996-03-20 2001-07-17 Smithkline Beecham Corporation IL-8 receptor antagonists
KR20000022274A (ko) * 1996-06-27 2000-04-25 스튜어트 알. 수터, 스티븐 베네티아너, 피터 존 기딩스 Il-8 수용체 길항제
IL127667A0 (en) 1996-06-27 1999-10-28 Smithkline Beecham Corp IL-8 receptor antagonists
WO1998006398A1 (en) * 1996-08-15 1998-02-19 Smithkline Beecham Corporation Il-8 receptor antagonists
US6492370B1 (en) 1998-03-26 2002-12-10 Santen Pharmaceutical Co., Ltd. Urea derivatives and pharmaceutical compositions thereof
US7465754B1 (en) 1999-09-15 2008-12-16 Wyeth Method of potentiating chemotherapy and treating solid tumors
IL163868A0 (en) * 2002-03-22 2005-12-18 Eisai Co Ltd Hermiasterlin derivatives and uses thereof
US7332158B2 (en) 2002-05-29 2008-02-19 Demao Yang Compositions and treatments for myelosuppression by ex vivo activated immune cells
US7048922B2 (en) * 2002-05-29 2006-05-23 Demao Yang Stimulation of hematopoiesis by ex vivo activated immune cells
TW200418812A (en) * 2002-10-29 2004-10-01 Smithkline Beecham Corp IL-8 receptor antagonists
US20060057121A1 (en) * 2004-09-10 2006-03-16 Demao Yang Compositions and treatments using ex vivo activated cells for myelosuppressed patients
AU2007240365B2 (en) * 2006-04-21 2011-12-15 Glaxosmithkline Llc IL-8 receptor antagonists
WO2007124423A2 (en) * 2006-04-21 2007-11-01 Smithkline Beecham Corporation Il-8 receptor antagonists
CL2007001829A1 (es) * 2006-06-23 2008-01-25 Smithkline Beecham Corp P-toluensulfonato de n-[4-cloro-2-hidroxi-3-(piperazina-1-sulfonil)fenil]-n-(2-cloro-3-fluorofenil)urea;procedimiento de preparacion;composicion farmaceutica;combinacion farmaceutica;y uso en el tratamiento de una enfermedad mediada por la quiimioquina il-8, tales como asma y epoc.
CN104302191A (zh) 2012-03-30 2015-01-21 奇华顿股份有限公司 用于改善可食用组合物香味特性的n-酰基-氨基酸衍生物
JP6250029B2 (ja) 2012-03-30 2017-12-20 ジボダン エス エー 食品フレーバー付与化合物としてのｎ−アシル−アミノ酸誘導体
BR112014024157B1 (pt) 2012-03-30 2020-12-15 Givaudan Sa Composição comestível, solução de estoque e método para complementar as características de sabor ou paladar de produtos comestíveis
CN104219965B (zh) 2012-03-30 2018-10-12 奇华顿股份有限公司 作为食品加香化合物的γ氨基-丁酸和β丙氨酸的N-酰基衍生物
KR102124224B1 (ko) 2012-03-30 2020-06-18 지보당 에스아 식품 향미 화합물로서의 n-아실화된 메티오닌 유도체
WO2013149025A1 (en) * 2012-03-30 2013-10-03 Givaudan, S., A. N-acyl serine derivatives as food flavouring compounds
CN104244734B (zh) 2012-03-30 2018-04-03 奇华顿股份有限公司 作为食品加香化合物的n‑酰化1‑氨基环烷基羧酸
SG11201405188XA (en) 2012-03-30 2014-11-27 Givaudan Sa N-acyl-amino acid derivatives as food flavouring compounds, powder compositions|containing them
US11122826B2 (en) 2013-10-02 2021-09-21 Givaudan Sa Organic compounds
CN105592720B (zh) 2013-10-02 2020-07-07 奇华顿股份有限公司 具有味道改进特性的有机化合物
WO2015050535A1 (en) 2013-10-02 2015-04-09 Givaudan S.A. Organic compounds
US10834950B2 (en) 2013-10-02 2020-11-17 Givaudan S.A. Organic compounds
WO2015048990A1 (en) 2013-10-02 2015-04-09 Givaudan Sa Organic compounds having taste-modifying properties
CN105636459A (zh) 2013-10-02 2016-06-01 奇华顿股份有限公司 有机化合物
GB201317424D0 (en) * 2013-10-02 2013-11-13 Givaudan Sa Improvements in or relating to organic compounds
EP3057446B1 (en) 2013-10-02 2017-12-06 Givaudan S.A. Organic compounds having taste-modifying properties
US10717703B2 (en) 2017-08-21 2020-07-21 Celgene Corporation Processes for the preparation of (S)-tert-butyl 4,5-diamino-5-oxopentanoate
CN109601739B (zh) * 2019-01-17 2022-10-14 河南湾流生物科技有限公司 一种复合氨基酸饲料添加剂及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2033906B (en) * 1978-10-19 1982-12-01 Anvar Water-soluble compounds derived from extracts of streptomyces stimulosus process for their production and compositions containing them
US4725582A (en) * 1978-11-14 1988-02-16 Fujisawa Pharmaceutical Company, Ltd. Peptide, process for preparation thereof and use thereof
US4349466A (en) * 1978-11-14 1982-09-14 Fujisawa Pharmaceutical Co Peptide, process for preparation thereof and use thereof
FR2460290A1 (fr) * 1979-06-29 1981-01-23 Rhone Poulenc Ind Nouveaux tetra- ou pentapeptides, leur preparation et les medicaments qui les contiennent
ES8604609A1 (es) * 1985-07-02 1986-02-01 Uriach & Cia Sa J Procedimiento para la obtencion de la 1-(n-(1(r,s)-(etoxi- carbonil)-3-fenilpropil)-l-alanil)-l-prolina
JPH06510769A (ja) * 1991-09-27 1994-12-01 ボード・オヴ・リージェンツ，ザ・ユニヴァーシティ・オヴ・テキサス・システム 低血圧症と関連疾患の治療のためのアミノ酸非経口製剤

Also Published As

Publication number Publication date
CZ290445B6 (cs) 2002-07-17
US5633280A (en) 1997-05-27
CN1100413A (zh) 1995-03-22
ATE144533T1 (de) 1996-11-15
SK281120B6 (sk) 2000-12-11
RU2135515C1 (ru) 1999-08-27
US5545662A (en) 1996-08-13
CZ98194A3 (en) 1994-12-15
AU6304394A (en) 1994-11-17
DE69400798T2 (de) 1997-03-13
HUT67038A (en) 1995-01-30
TW380129B (en) 2000-01-21
DE69400798D1 (de) 1996-11-28
NO941786D0 (no) 1994-05-11
SI0652228T1 (en) 1997-10-31
PL179984B1 (pl) 2000-11-30
US5602275A (en) 1997-02-11
NZ260507A (en) 1996-02-27
FI942186A0 (fi) 1994-05-11
HU219768B (hu) 2001-07-30
JP3583469B2 (ja) 2004-11-04
SK49194A3 (en) 1995-02-08
DK0652228T3 (da) 1996-11-25
IL109602A0 (en) 1994-08-26
ES2094004T3 (es) 1997-01-01
US5658945A (en) 1997-08-19
US5616612A (en) 1997-04-01
NO311223B1 (no) 2001-10-29
KR100296543B1 (ko) 2001-11-22
ZA943266B (en) 1995-01-12
JPH07179414A (ja) 1995-07-18
PH30182A (en) 1997-01-21
EP0652228B1 (en) 1996-10-23
IL109602A (en) 2000-06-01
GR3022253T3 (en) 1997-04-30
CN1094943C (zh) 2002-11-27
AU669064B2 (en) 1996-05-23
CA2123261A1 (en) 1994-11-13
FI942186L (fi) 1994-11-13
HU9401444D0 (en) 1994-08-29
US5312831A (en) 1994-05-17
NO941786L (no) 1994-11-14
EP0652228A1 (en) 1995-05-10
FI942186A7 (fi) 1994-11-13

Similar Documents

Publication Publication Date Title
PH30182A (en) Urethanes and ureas that induce cytokine production
RU94016389A (ru) Карбаматы и карбамиды, индуцирующие производство цитокинов
IL150223A (en) Lipopeptides and pharmaceuticals containing them
MXPA02006030A (es) Lipopeptidos como agentes antibacterianos.
MXPA04000024A (es) Metodos para inducir una respuesta inmunologica citotoxica y composiciones de adenovirus simio recombinante utiles en los mismos.
CY1107351T1 (el) Καινοφανης μεταλλαγμενη μορφη απιμινασης αργινινης
WO1993016099A3 (en) Dna sequences encoding novel growth/differentiation factors
MXPA05009885A (es) Nuevas triazolonas fusionadas y los usos de las mismas.
MY129376A (en) Novel pharmaceutical formulations of modafinil
IL196900A0 (en) Autologous t-cell vaccines compositions
IL160171A0 (en) Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
YU174491A (sh) Vakcine
AU8163294A (en) Branched-amino-substituted thiazoles, processes for their preparation and the pharmaceutical compositions which contain them
BR0002577A (pt) Suspensões orais de trovafloxacina
TW200500097A (en) Novel pharmaceutical formulations of modafinil
ATE213233T1 (de) Substituierte caprolactame und deren derivate verwendbar zur behandlung der hiv-krankheit
MXPA04001655A (es) Derivados de acido ascorbico, metodos de sintesis y uso farmaceutico de los mismos.
DE60304989D1 (de) Zusammensetzungen enthaltend fötales Hämoglobin und bakterielles Endotoxin und fakultativ zusätzliche fötale Leberkomponenten
ATE530194T1 (de) Immunomodulierende zusammensetzung die eine partikelfraktion von bakteriellen mechanischen lysates enthält
MY103593A (en) Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation
SE9902147D0 (sv) Nya föreningar och farmaceutiska kompositioner innehållande desamma